Royalty Pharma PLC RPRX 3.35 09/02/51

Royalty Pharma PLC RPRX 3.35 09/02/51 is a security (CUSIP 78081BAP8) tracked across SEC portfolio filings. 3 registered fund positions totaling $3.5M via N-PORT as of 2026-05-31.

Summary

Top fund holders (N-PORT)

FundRegistrantValue% of fund
Franklin Investment Grade Corporate ETFFranklin Templeton ETF Trust$1.9M31.86%
Lord Abbett Total Return FundLORD ABBETT INVESTMENT TRUST$1.3M3.54%
VANGUARD BALANCED INDEX FUNDVANGUARD VALLEY FORGE FUNDS$323K0.05%

More